In fact, in the liver, the pan-macrophage marker CD68 was frequently co-expressed with Gal-3 and the number of double-positive cells was reduced in groups with steatosis, hepatocyte ballooning, and NASH. This evidence concerns the gene CD68 and metabolic dysfunction-associated steatohepatitis.